Jian You
Tianjin Medical University Cancer Institute and Hospital · 51 works · 1,408 citations · h-index 14
Top works
- Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
- Abstract CT005: AEGEAN: A phase 3 trial of neoadjuvant durvalumab + chemotherapy followed by adjuvant durvalumab in patients with resectable NSCLC
- New insight on the correlation of metabolic status on 18F-FDG PET/CT with immune marker expression in patients with non-small cell lung cancer
- The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis
- Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection
- Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC
- Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC)
- Case report: Durable response of ensartinib targeting EML4-ALK fusion in osimertinib-resistant non-small cell lung cancer
- Do Tumor Cavitation and Sex in Resected Stage I Non‐Small‐Cell Lung Cancer Correlate with Prognosis?
- Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines
- Survival benefit and toxicity profile of adjuvant icotinib for patients with EGFR mutation-positive non-small cell lung carcinoma: a retrospective study
- Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis
- Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
- Feasibility of sleeve lobectomy after neo-adjuvant chemo-immunotherapy in non-small cell lung cancer
- Neoantigen cancer vaccines: a new star on the horizon
- MHSnet: Multi-head and Spatial Attention Network with False-Positive Reduction for Lung Nodule Detection
- Combining antiangiogenic therapy with neoadjuvant chemotherapy increases treatment efficacy in stage IIIA (N2) non-small cell lung cancer without increasing adverse effects
- [Treatment and prognostic analysis of 1638 patients with non-small cell lung cancer].
- LIDP: A Lung Image Dataset with Pathological Information for Lung Cancer Screening
- Pathologic responses to neoadjuvant chemoimmunotherapy in primary limited‐stage small‐cell lung cancer